SCHEMBL3175479

SCHEMBL3175479

Cc1ccc(-c2oncc2C(=O)O)cc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.51
ALPL P05186 1/20 0.43
CA9 Q16790 1/20 0.43
ALDH1A1 P00352 4/20 0.40
RARA P10276 3/20 0.40
RARB P10826 3/20 0.40
RARG P13631 3/20 0.40
XDH P47989 1/20 0.40
SLC22A12 Q96S37 1/20 0.40
NOTUM Q6P988 1/20 0.39
LDHA P00338 1/20 0.39
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
RXRB P28702 2/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
RXRA P19793 1/20 0.37
CYP1A2 P05177 1/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3173623 0.82 SMN1; SMN2 (0.46) MCL1ALPLALDH1A1XDHSLC22A12
SCHEMBL3171124 0.80 IP6K1 (0.51) MCL1ALDH1A1LDHAHCRTR1HCRTR2
SCHEMBL27830583 0.79 IP6K1 (0.46) MCL1ALDH1A1NOTUMLDHAHCRTR1
SCHEMBL544183 0.76 PTPN1 (0.47) MCL1ALDH1A1LDHAHCRTR1HCRTR2
SCHEMBL3175389 0.76 NPC1 (0.44) ALPLALDH1A1XDHSLC22A12NOTUM
SCHEMBL3180927 0.76 BCL2L1 (0.44) ALPLALDH1A1XDHSLC22A12NPC1
SCHEMBL343121 0.76 PTPN1 (0.46) MCL1ALDH1A1KDM4E
SCHEMBL3546598 0.75 ALDH1A1 (0.56) ALPLCA9ALDH1A1NPC1RAB9A
SCHEMBL3549276 0.74 DCLRE1B (0.47) ALDH1A1NOTUMKDM4E
SCHEMBL3178747 0.74 NPC1 (0.50) RXRBNPC1RAB9ARXRACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231650-A1 ISOXAZOLE DERIVATIVES AS MODULATORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 Biovitrum AB (publ) (SE) 2010-09-29 EP disclosed
US-20100022590-A1 Novel compounds BIOVITRUM AB (PUBL.) (SE) 2010-01-28 US disclosed
WO-2009090239-A1 ISOXAZOLE DERIVATIVES AS MODULATORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB (PUBL) (SE) 2009-07-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022590-A1 Novel compounds HSD11B1, CYP11B1, HSD11B2 MCL1 4424/4885ALPL 613/4885CA9 601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.